Newsletter | October 10, 2025

10.10.25 -- CDMO Hunger Games And The State Of Biotech

FEATURED ARTICLE

CDMO Hunger Games And The State Of Biotech

Biotech leader Nicole Paulk, Ph.D., joins Better Biopharma to discuss Siren Biotechnology’s switch from plasmids to producer cell lines, CGT funding challenges, and the competition that determined which CDMO won Siren’s business.

INDUSTRY INSIGHTS

Agentic AI And How It's Impacting Clinical Trial Research

Since ChatGPT’s launch in 2022, artificial intelligence has transformed industries worldwide—but the next evolution, Agentic AI, promises to be even more profound.

Why Bioanalysis Needs To Break Free From Manual Bottlenecks

Bioanalysis remains one of the most persistent bottlenecks in drug development, with CRO's displaying inefficiencies that are no longer operational nuisances but strategic liabilities.

6 Clinical Trial Patient Retention Tips And Strategies

Examine the critical issue of patient retention in clinical trials and six practical strategies to help CROs, biopharma companies, and clinical trial staff address these challenges.

AAV Analytics: Key Considerations When Developing A Clinical Program

Finding partners with the necessary skills to optimize AAV processes is crucial for minimizing risk. Explore key considerations for advancing your therapy from concept to commercialization.

Utilizing Nanoparticle Technologies For A More Sustainable Value Chain

The pharma industry is identifying ways to make processes more sustainable. Learn how nanoparticle engineering technology can both empower sustainability goals and lead to better patient outcomes.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines Life Science Leader

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.